Sun Pharma surpasses SBI in market valuation

Drug major Sun Pharmaceutical Industries on Tuesday surpassed SBI, country's largest public sector lender, in terms of market valuation.

Sun Pharma's market capitalisation (m-cap) increased to Rs 2,15,394.82 crore, following over one per cent rally in the stock at the BSE, overtaking SBI whose valuation stood at Rs 2,09,488.41 crore during the afternoon trade.

SBI's scrip was trading 0.48 per cent lower at Rs 280.30. With this, Sun Pharma now stands at eight position in the list of top-10 most valued companies in terms of their market capitalisation, followed by SBI at ninth place.

TCS is the most valued Indian company with a market cap of Rs 5,04,068.85 crore, followed by RIL, ITC, ONGC, HDFC Bank, Infosys, CIL, Sun Pharma, SBI and HDFC.

Market capitalisation of a listed company corresponds to the cumulative market price of all its shares. This figure changes daily with change in stock price.